Tipping the scales toward fitness as a key modifier of the obesity paradox in heart failure

European Journal of Heart Failure

Volumn 18, Issue 5, 2016, Pages 554-555

  Clark, Adrienne L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

BODY FAT; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; EXERCISE TOLERANCE; GLUCOSE TOLERANCE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; NOTE; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

BODY MASS INDEX; HEART FAILURE; HUMANS; OBESITY;

EID: 84964816136     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.545     Document Type: Note

References (16)

1. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO,. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013; 1: 93-102.
2. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH,. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789-795.
3. Clark AL, Fonarow GC, Horwich TB,. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 2011; 17: 374-380.
4. Clark AL, Fonarow GC, Horwich TB,. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 2014; 56: 409-414.
5. Lavie CJ, Osman AF, Milani RV, Mehra MR,. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003; 91: 891-894.
6. Zavin A, Daniels K, Arena R, Allsup K, Lazzari A, Joseph J, Schulze PC, Lecker SH, Forman DE,. Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction. Int J Cardiol 2013; 167: 2468-2471.
7. Maaten ter JM, Damman K, Hillege HL, Bakker SJ, Anker SD, Navis G, Voors AA,. Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure. Clin Res Cardiol 2014; 103: 976-983.
8. Task Force of the Italian Working Group on Cardiac Rehabilitation and Prevention (Gruppo Italiano di Cardiologia Riabilitativa e Prevenzione, GICR), Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part III: interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. Eur J Cardiovasc Prev Rehabil 2006; 13: 485-494.
9. Khan H, Kella D, Rauramaa R, Savonen K, Lloyd MS, Laukkanen JA,. Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm 2015; 12: 1424-1430.
10. Khan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos AP, Georgiopoulou VV, Butler J, Laukkanen JA,. Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study. Eur J Heart Fail 2014; 16: 180-188.
11. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR,. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-786.
12. Piepoli MF, Corrà U, Veglia F, Bonomi A, Salvioni E, Cattadori G, Metra M, Lombardi C, Sinagra G, Limongelli G, Raimondo R, Re F, Magri D, Belardinelli R, Parati G, Mina C, Scardovi A, Guazzi M, Cicoira M, Scrutinio D, Di Lenarda A, Bussotti M, Frigerio M, Correale M, Quinto Villani G, Paolillo S, Passino C, Agostoni P, on behalf of the MECKI Score Research Group. Exercise tolerance can explain the obesity paradox in heart failure: data from the MECKI Score Research Group. Eur J Heart Fail 2016; 18: 545-553.
13. Clark AL, Fonarow GC, Horwich TB,. Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol 2015; 115: 209-213.
14. Rivera M, Cortés R, Salvador A, Bertomeu V, de Burgos FG, Payá R, Portolés M, Taléns-Visconti R, Martinez-Dolz L, Valero R, Sevilla B, Climent V,. Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 2005; 7: 1168-1170.
15. Lindberg S, Jensen JS, Bjerre M, Pedersen SH, Frystyk J, Flyvbjerg A, Mogelvang R,. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide, and incident heart failure. Eur J Heart Fail 2014; 16: 633-638.
16. Forman DE, Sanderson BK, Josephson RA, Raikhelkar J, Bittner V, American College of Cardiology's Prevention of Cardiovascular Disease Section. Heart failure as a newly approved diagnosis for cardiac rehabilitation: challenges and opportunities. J Am Coll Cardiol 2015; 65: 2652-2659.